Biopharmaceutical company Fulcrum Therapeutics recently disclosed that by the end of 2025, its total holdings of cash, cash equivalents, and marketable securities will reach $352.3 million.
Show original
This capital scale is expected to support the company's operations until 2029, demonstrating strong financial resilience and long-term development potential.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Analyst: Gold Will Regain Its Position as the Preferred Safe-Haven Asset
Odaily星球日报•2026/03/01 14:17
If Bitcoin drops below $65,000, the mainstream CEX long liquidation intensity will reach 736 million.
BlockBeats•2026/03/01 13:26
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$67,024.51
+3.41%
Ethereum
ETH
$2,017.74
+6.26%
Tether USDt
USDT
$1
-0.01%
BNB
BNB
$628.13
+4.13%
XRP
XRP
$1.39
+4.69%
USDC
USDC
$1
+0.02%
Solana
SOL
$86.41
+7.03%
TRON
TRX
$0.2821
+0.73%
Dogecoin
DOGE
$0.09485
+4.34%
Cardano
ADA
$0.2825
+5.40%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now